Kane Biotech Inc.

Kane Biotech Inc.

Biotechnology Research

Winnipeg, Manitoba 4,723 followers

Kane is actively advancing technologies and products that break up biofilms and destroy bacteria.

About us

With 81 patents and patents pending, Kane Biotech is Kane Biotech is THE Biofilm Company. Creating smarter ways to fight bacteria, Kane is leading the advancement of technologies and products that break up biofilms and destroy bacteria. Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. StrixNB™, DispersinB®, Aledex™, bluestem™, bluestem®, silkstem™, goldstem™, coactiv+™, coactiv+®, DermaKB™ and DermaKB Biofilm™ are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE" and on the OTCQB Venture Market under the symbol “KNBIF”.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Winnipeg, Manitoba
Type
Public Company
Founded
2001
Specialties
Animal Health, Bacterial Biofilm Dispersion, Human Health, Innovation, and Global Partnership

Locations

  • Primary

    162 - 196 Innovation Dr.

    Winnipeg, Manitoba R3T 2N2, CA

    Get directions

Employees at Kane Biotech Inc.

Updates

Similar pages

Browse jobs

Funding

Kane Biotech Inc. 22 total rounds

Last Round

Post IPO equity

US$ 500.0K

See more info on crunchbase